Claim Your Free
Staff Education Wallboard!

Email-id is invalid

For latest News and updates

Allergy Cardiology Critical Care Dermatology Diabetes Emergency Gastroenterology Infectious Disease Neurology Nephrology OBGYN Oncology Opththalmology Pain Pediatrics Primary Care Pulmonology Psychiatry Rheumatology Surgery

SaveNot Now

Please select specialty

SaveNot Now

Home
Specialties
Doctor’s Voice
Meeting Coverage
Continuing Education
Podcast
#PWChat
Covid-19

Select Page

Home » Oncology / Hematology » Oncology / Hematology Newsletter

Oncology / Hematology Newsletter

UK Age Trial: Yearly Mammography Beginning at Age 40 Reduced Breast Cancer Mortality over 10 Years

Jan 4, 2021

Finding attenuated after 10 years and authors noted a ’modest overdiagnosis,’ which a...

ASTRO Issues Guideline on Radiation Therapy for Rectal Cancer

Oct 27, 2020

MONDAY, Oct. 26, 2020 (HealthDay News) — In a clinical practice guideline issued by the...

Rurality, Income Impact Stage at Diagnosis, Mortality in Liver Cancer

Oct 27, 2020

MONDAY, Oct. 26, 2020 (HealthDay News) — Patients with hepatocellular carcinoma (HCC) from...

ESMO: Abemaciclib Reduces Risk of Invasive Breast Cancer

Sep 24, 2020

Combination with endocrine therapy benefits high-risk patients Women with high-risk breast cancer...

ESMO: Is KRAS Finally ’Druggable’?

Sep 23, 2020

Sotorasib results promising in phase 1 trial Results of a 129-patient phase I trial of sotorasib,...

ESMO: PROfound Final Analysis Confirms Olaparib Benefit in Tumors with BRCA1, BRCA2, or ATM Alterations

Sep 23, 2020

Longer overall survival for castration-resistant metastatic prostate ca In men whose...

A Welcome Guideline for Managing Newly Diagnosed AML in Older Adults

Sep 21, 2020

Acute myeloid leukemia (AML) generally develops in patients who fall into the “baby boomer”...

Another Coffee Perk—Prolonged Survival in Metastatic Colorectal Cancer?

Sep 21, 2020

Antioxidants in coffee may block cancer progression Coffee packed an unexpected “perk”...

TRITON2 Safety and Efficacy Findings Confirm PARP Benefit in mCRPC

Sep 18, 2020

Greater PSA response seen in BRCA2 alterations The poly (ADP-ribose) polymerase (PARP) inhibitor...

Bevacizumab and Platinum-Based Combinations for Recurrent Ovarian Cancer

Sep 17, 2020

Bevacizumab is a medication used to treat a wide range of cancers. Bevacizumab, along with carboplatin-paclitaxel, carboplatin–gemcitabine, or carboplatin–pegylated liposomal doxorubicin, is used as a state-of-the-art therapy...